Skip to main content
. 2014 Jun 11;30(12):i69–i77. doi: 10.1093/bioinformatics/btu272

Table 3.

Top upstream regulators selected by Bayes-CRE in response to infliximab treatment in UC patients

Rank Upstream regulator Direction Probability
1 IFNG Down 1.00
2 LPS Down 1.00
3 TNF Down 0.99
4 Retinoic acid Down 0.92
5 SE LPS Down 0.89
6 Poly rI:rC-RNA Down 0.86
7 Decitabine Down 0.82
8 Allergens Down 0.77
9 IL1 Down 0.62